321 related articles for article (PubMed ID: 23136183)
41. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
Upton ML; Tangner CH; Payton ME
J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.
Sotirakopoulos AJ; Armstrong PJ; Heath L; Madrill NJ; McNiel EA
J Vet Intern Med; 2010; 24(6):1445-51. PubMed ID: 21039871
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H
Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300
[TBL] [Abstract][Full Text] [Related]
44. Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma.
Inoue A; Maeda S; Kinoshita R; Tsuboi M; Yonezawa T; Matsuki N
Vet Immunol Immunopathol; 2017 Aug; 190():53-56. PubMed ID: 28778323
[TBL] [Abstract][Full Text] [Related]
45. [Skin metastasis from transitional cell carcinoma of the bladder].
Alvarez Castelo LM; García Freire C; Rodríguez-Rivera García J; Lancina Martín JA; González Martín M
Arch Esp Urol; 1995 Sep; 48(7):749-50. PubMed ID: 7487184
[TBL] [Abstract][Full Text] [Related]
46. [Cutaneous metastases from transitional cell carcinoma of the bladder].
Takigawa H; Kagawa S; Aga Y; Furukawa A; Inai T; Kurokawa K
Hinyokika Kiyo; 1989 Jun; 35(6):1061-3. PubMed ID: 2801394
[TBL] [Abstract][Full Text] [Related]
47. Superficially invasive transitional cell carcinoma of the bladder associated with distant cutaneous metastases.
Swick BL; Gordon JR
J Cutan Pathol; 2010 Dec; 37(12):1245-50. PubMed ID: 19919656
[TBL] [Abstract][Full Text] [Related]
48. Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series.
Ricardo Huppes R; Crivellenti LZ; Barboza De Nardi A; Roque Lima B; Alves Cintra C; Luiz Costa Castro J; Adin CA
Vet Surg; 2017 Jan; 46(1):111-119. PubMed ID: 27911468
[TBL] [Abstract][Full Text] [Related]
49. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
Packeiser EM; Hewicker-Trautwein M; Thiemeyer H; Mohr A; Junginger J; Schille JT; Murua Escobar H; Nolte I
PLoS One; 2020; 15(3):e0230272. PubMed ID: 32168360
[TBL] [Abstract][Full Text] [Related]
50. Transitional cell carcinoma metastatic to the eye of a dog.
Schmidt RE
Vet Pathol; 1981 Nov; 18(6):832-4. PubMed ID: 7292899
[No Abstract] [Full Text] [Related]
51. Needle tract implantation after fine needle aspiration biopsy (FNAB) of transitional cell carcinoma of the urinary bladder and adenocarcinoma of the lung.
Vignoli M; Rossi F; Chierici C; Terragni R; De Lorenzi D; Stanga M; Olivero D
Schweiz Arch Tierheilkd; 2007 Jul; 149(7):314-8. PubMed ID: 17702491
[TBL] [Abstract][Full Text] [Related]
52. [Bladder cancer with skin metastasis: a case report].
Segawa N; Kotake Y; Hamada S; Takahara K; Azuma H; Katsuoka Y; Tsuji M
Hinyokika Kiyo; 2006 Sep; 52(9):711-4. PubMed ID: 17040057
[TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors in dogs with urinary bladder carcinoma.
Rocha TA; Mauldin GN; Patnaik AK; Bergman PJ
J Vet Intern Med; 2000; 14(5):486-90. PubMed ID: 11012109
[TBL] [Abstract][Full Text] [Related]
55. Transitional cell carcinoma metastasis to arm skin from the renal pelvis.
Lin CY; Lee CT; Huang JS; Chang LC
Chang Gung Med J; 2003 Jul; 26(7):525-9. PubMed ID: 14515977
[TBL] [Abstract][Full Text] [Related]
56. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines.
Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N
Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405
[TBL] [Abstract][Full Text] [Related]
57. Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder.
Naughton JF; Widmer WR; Constable PD; Knapp DW
Am J Vet Res; 2012 Dec; 73(12):1919-24. PubMed ID: 23176418
[TBL] [Abstract][Full Text] [Related]
58. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
Gustafson TL; Biller B
J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
[No Abstract] [Full Text] [Related]
59. A population study of neutering status as a risk factor for canine prostate cancer.
Bryan JN; Keeler MR; Henry CJ; Bryan ME; Hahn AW; Caldwell CW
Prostate; 2007 Aug; 67(11):1174-81. PubMed ID: 17516571
[TBL] [Abstract][Full Text] [Related]
60. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
